ASCO Genitourinary Cancers Symposium 2025 (Videos + Slides + Posters)

Overview

The ASCO Genitourinary Cancers Symposium 2025 (Videos + Slides + Posters) provides comprehensive, multidisciplinary insights into recent clinical and scientific progress in genitourinary oncology, covering prostate, urothelial, renal cell, and other related cancers. This on-demand digital product includes videos, slides, and posters originally presented at the live symposium, now accessible for convenient review and study.

On-demand urology education — accessible anytime, anywhere.

Agenda

This program features expert presentations, case-based sessions, poster discussions, networking opportunities, and abstract sessions focusing on the latest research and clinical advances in genitourinary cancers.

• Oral Abstract Session A: Prostate Cancer — Kosj Yamoah, MD, PhD; Channing Judith Paller, MD
• Understanding Radioligand Therapies for Advanced Prostate Cancer — Angela Y Jia, MD, PhD; Devaki Shilpa Surasi, MBBS
• Poster Session A: Prostate Cancer With Complimentary Boxed Lunch
• Case-Based Session: Management of Biochemical Recurrence After Radiation Therapy for Localized Prostate Cancer — Michael Cookson, MD, MMHC, FACS; Barbara Jereczek-Fossa, MD
• Keynote: Creative Innovation: Driving Science to Improve Patient-Centered Care — Peter Hoskin, MD, FRCP, FRCR; William L. Dahut, MD
• Case-Based Session: Evolving Landscape of the Management of Oligometastatic Disease — Karen E. Hoffman, MD, MHSc, MPH; Nicholas David James
• Rapid Oral Abstract Session A: Prostate Cancer — Marjory Jolicoeur, MD, PhD, FRCPC
• Poster Walks and Networking Sessions for Prostate Cancer and Women’s Networking Reception
• Oral Abstract Session B: Urothelial Carcinoma — Elizabeth A. Guancial, MD; Nicholas I. Simon, MD, MSc
• Case-Based Session: Non-Muscle Invasive Bladder Cancer: Exploring Therapies Beyond Bacillus Calmette-Guérin — Brian Christopher Baumann, MD; Bogdana Schmidt, MD, MPH
• Poster Session B: Urothelial Carcinoma With Complimentary Boxed Lunch
• Breakout Session: Emerging Trends and Advances in Germ Cell Tumors — Aditya Bagrodia, MD; Anja Lorch, MD
• The ABCs of ADCs: Unleashing the Power of Antibody-Drug Conjugates in Advanced Bladder Cancer — Kent William Mouw, MD, PhD; Benjamin Garmezy, MD
• Panning for Gold: The Role of ctDNA as a Biomarker for Bladder Cancer — Bernadett Szabados, MBBS; Joaquim Bellmunt, MD
• Rapid Oral Abstract Session B: Urothelial Carcinoma — Katie S. Murray, DO, FACS, MS
• Poster Walks and Networking Sessions for Urothelial Carcinoma
• Poster Sessions and Trials in Progress for Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral Cancers
• Oral Abstract Session C: Renal Cell Cancer — Arpita Desai, MD; Daniel Shapiro
• Biomarkers and Adjuvant Therapy for Renal Cell Carcinoma: Current State and Future Directions — Shuchi Gulati, MD, MS, FACP; Axel Bex, MD, PhD
• Rapid Oral Abstract Session C: Renal Cell Cancer — Brittney Cotta, MD
• Case-Based Session: Failure of Immunotherapy in Renal Cell Cancer: What’s Next? — Leslie K. Ballas, MD; Kathryn Hacker Gessner, MD, PhD

Speakers

This symposium features contributions from a broad spectrum of multidisciplinary experts in genitourinary oncology. Presentations include researchers, clinicians, and specialists in medical oncology, radiation oncology, urology, radiology, and related fields. These experts provide authoritative discussions on emerging research, clinical trials, and therapeutic strategies in genitourinary cancers.

Target Audience

This content is designed for oncologists, urologists, radiation oncologists, medical researchers, healthcare professionals, and clinicians involved in the management and treatment of genitourinary cancers seeking to update their knowledge base with the latest evidence and clinical advances.

Why This Topic Matters

The ASCO Genitourinary Cancers Symposium 2025 (Videos + Slides + Posters) is a vital resource for professionals specializing in genitourinary oncology. The symposium consolidates the latest advancements in diagnosis, treatment, and research of prostate, bladder, renal, and other genitourinary cancers, supporting clinicians in strengthening their expertise and clinical decision-making.

MedHub Central offers access to this extensive educational material, enabling oncology and urology specialists to deepen their understanding of complex genitourinary malignancies and to stay abreast of evolving therapeutic approaches relevant to their clinical practice.